Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Genzyme Canada, a division of sanofi-aventis Canada Inc.
01 12443285
01 1TERIFLUNOMIDE
01 1TABLET
01 12022-04-04
Patent Expiration Date : 2022-04-04
Date Granted : 2007-08-21
Brand Name : AUBAGIO
Patent Number : 2443285
Filing Date : 2002-04-04
Strength per Unit : 14 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-04-04
Date Granted : 2007-08-21
LOOKING FOR A SUPPLIER?